Suppr超能文献

基层医疗中囊性纤维化检测的应用:供应推动还是需求拉动?

Uptake of cystic fibrosis testing in primary care: supply push or demand pull?

作者信息

Bekker H, Modell M, Denniss G, Silver A, Mathew C, Bobrow M, Marteau T

机构信息

Wellcome Psychology and Genetics Research Group, United Medical School of Guy's Hospital, London.

出版信息

BMJ. 1993 Jun 12;306(6892):1584-6. doi: 10.1136/bmj.306.6892.1584.

Abstract

OBJECTIVE

To determine the acceptability and feasibility of screening for carriers of cystic fibrosis in a primary care setting.

DESIGN

Follow up study over 15 months of patients offered carrier testing by mouthwash.

SETTING

A general practice in inner London.

SUBJECTS

5529 patients aged 18-45 invited by various methods and combinations of methods (letter, booklet, personal approach) for testing.

MAIN OUTCOME MEASURES

Uptake of screening, anxiety, and knowledge of test.

RESULTS

957 (17%) invitees were screened over the 15 months. 28 carriers and no carrier couples were detected. Uptake rates were 12% (59/502 patients) among patients invited by letter and tested by appointment; 9% (47/496) among patients invited by letter, with leaflet, and tested by appointment; 4% (128/2953) among patients invited by letter six weeks before the end of the study and tested by appointment; 17% (81/471) among patients offered passive opportunistic testing; 70% (453/649) among patients offered active opportunistic testing; and 25% (22/88) among patients offered active opportunistic testing by appointment. A short term rise in anxiety among those given a positive test result had dissipated by three months. At three months about one fifth and one third of those given positive and negative results respectively did not understand their results correctly.

CONCLUSION

These results suggest that the strongest variable in determining uptake of screening is the active approach by a health professional offering immediate testing. It remains to be resolved whether the high uptake rates achieved by active recruitment indicate a supply push for this new test rather than a demand from the population.

摘要

目的

确定在基层医疗环境中筛查囊性纤维化携带者的可接受性和可行性。

设计

对通过漱口水进行携带者检测的患者进行为期15个月的随访研究。

地点

伦敦市中心的一家普通诊所。

研究对象

通过多种方法及方法组合(信件、手册、个人接触)邀请5529名年龄在18至45岁之间的患者进行检测。

主要观察指标

筛查的接受情况、焦虑程度以及对检测的了解程度。

结果

在15个月内,957名(17%)受邀者接受了筛查。检测出28名携带者,未发现携带者夫妇。通过信件邀请并预约检测的患者中,接受率为12%(59/502例患者);通过信件并附带传单邀请且预约检测的患者中,接受率为9%(47/496例);在研究结束前六周通过信件邀请并预约检测的患者中,接受率为4%(128/2953例);接受被动机会性检测的患者中,接受率为17%(81/471例);接受主动机会性检测的患者中,接受率为70%(453/649例);通过预约接受主动机会性检测的患者中,接受率为25%(22/88例)。检测结果呈阳性者的焦虑在短期内有所上升,但三个月后已消退。三个月时,检测结果呈阳性和阴性的患者中,分别约有五分之一和三分之一没有正确理解检测结果。

结论

这些结果表明,决定筛查接受率的最主要变量是健康专业人员采用主动方式提供即时检测。主动招募所实现的高接受率是表明对这项新检测的供应推动而非人群需求,这一问题仍有待解决。

相似文献

1
Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
BMJ. 1993 Jun 12;306(6892):1584-6. doi: 10.1136/bmj.306.6892.1584.
3
The impact of population based screening for carriers of cystic fibrosis.
J Med Genet. 1994 May;31(5):364-8. doi: 10.1136/jmg.31.5.364.
4
Cystic fibrosis carrier testing in early pregnancy by general practitioners.
BMJ. 1993 Jun 12;306(6892):1580-3. doi: 10.1136/bmj.306.6892.1580.
5
Screening for carriers of cystic fibrosis through primary health care services.
BMJ. 1991 Aug 31;303(6801):504-7. doi: 10.1136/bmj.303.6801.504.
6
Active cascade testing for carriers of cystic fibrosis gene.
BMJ. 1994 Jun 4;308(6942):1462-7. doi: 10.1136/bmj.308.6942.1462.
8
Antenatal screening for cystic fibrosis: a trial of the couple model.
BMJ. 1994 Jun 4;308(6942):1459-62. doi: 10.1136/bmj.308.6942.1459.

引用本文的文献

1
Societal implications of expanded universal carrier screening: a scoping review.
Eur J Hum Genet. 2023 Jan;31(1):55-72. doi: 10.1038/s41431-022-01178-8. Epub 2022 Sep 12.
2
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Cochrane Database Syst Rev. 2021 Oct 11;10(10):CD010849. doi: 10.1002/14651858.CD010849.pub4.
3
The evolving landscape of expanded carrier screening: challenges and opportunities.
Genet Med. 2019 Apr;21(4):790-797. doi: 10.1038/s41436-018-0273-4. Epub 2018 Sep 24.
5
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Cochrane Database Syst Rev. 2018 Mar 14;3(3):CD010849. doi: 10.1002/14651858.CD010849.pub3.
6
Common methods of measuring 'informed choice' in screening participation: Challenges and future directions.
Prev Med Rep. 2016 Oct 28;4:601-607. doi: 10.1016/j.pmedr.2016.10.017. eCollection 2016 Dec.
7
Responsible implementation of expanded carrier screening.
Eur J Hum Genet. 2016 Jun;24(6):e1-e12. doi: 10.1038/ejhg.2015.271. Epub 2016 Mar 16.
8
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD010849. doi: 10.1002/14651858.CD010849.pub2.
9
Update and Review: Cystic Fibrosis.
J Genet Couns. 1999 Jun;8(3):137-62. doi: 10.1023/A:1022853822424.
10
Preconception care: promoting reproductive planning.
Reprod Health. 2014 Sep 26;11 Suppl 3(Suppl 3):S2. doi: 10.1186/1742-4755-11-S3-S2.

本文引用的文献

1
Simple non-invasive method to obtain DNA for gene analysis.
Lancet. 1988 Jun 18;1(8599):1356-8. doi: 10.1016/s0140-6736(88)92178-2.
2
Identification of the cystic fibrosis gene: chromosome walking and jumping.
Science. 1989 Sep 8;245(4922):1059-65. doi: 10.1126/science.2772657.
3
Community attitudes to cystic fibrosis carrier testing in England: a pilot study.
Prenat Diagn. 1989 Oct;9(10):727-34. doi: 10.1002/pd.1970091008.
4
Cutaneous reactions in relation to the use of 'TED'-stockings.
Lancet. 1989 Dec 2;2(8675):1346. doi: 10.1016/s0140-6736(89)91962-4.
5
Identification of the cystic fibrosis gene: genetic analysis.
Science. 1989 Sep 8;245(4922):1073-80. doi: 10.1126/science.2570460.
6
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
Science. 1989 Sep 8;245(4922):1066-73. doi: 10.1126/science.2475911.
7
Community attitudes to cystic fibrosis carrier screening.
Prenat Diagn. 1990 Apr;10(4):275-6. doi: 10.1002/pd.1970100413.
9
Methods for analysis of multiple cystic fibrosis mutations.
Hum Genet. 1991 Sep;87(5):613-7. doi: 10.1007/BF00209023.
10
Screening for carriers of cystic fibrosis through primary health care services.
BMJ. 1991 Aug 31;303(6801):504-7. doi: 10.1136/bmj.303.6801.504.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验